Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance

Transplantation

Volumn 68, Issue 11, 1999, Pages 1736-1745

  Sharland, Alexandra ^a   Yiqun, Yan ^b   Wang, Chuanmin ^b   Bowen, David G ^b   Junhong, Sun ^b   Sheil, A G Ross ^b   McCaughan, Geoffrey W ^b   Bishop, G Alex ^b  

^a CENTENARY INSTITUTE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; IMMUNOLOGICAL TOLERANCE; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0343446130     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199912150-00018     Document Type: Article

References (76)

1. Cordier G, Garnier H, Clot J, et al. La greffe de foie orthotopique chez le porc; premiers resultats. Mem Acad Chir 1965; 92: 27.
2. Calne R, Davis D, Hadjiyannaks E, et al. Prolonged survival of liver transplants in the pig. Br Med J 1967; 2: 478.
3. Peacock J, Terblanche J. Orthotopic homotransplantation of the liver in the pig. In: Read A, ed. The liver. London: Butterworths, 1967: 333.
4. Kamada N. The immunology of experimental liver transplantation in the rat. Immunology 1985; 55: 369.
5. Qian S, Lu L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts. Evidence for deletion of cytotoxic T cells and Implications for tolerance induction. J Immunol 1997; 158: 4654.
6. Kamada N, Wight DGD. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 1984; 38: 217.
7. Sharland A, Shastry S, Wang C, et al. Kinetics of intragraft cytokine expression, cellular infiltration and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model. Early activation and apoptosis is associated with liver graft acceptance. Transplantation 1998; 65: 1370.
8. Kamada N, Brons I, Davies H. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980; 29: 429.
9. Zavazava N, Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 1996; 2: 1005.
10. Buelow R, Burlingham W, Clayberger C. Immunomodulation by soluble HLA class I. Transplantation 1995; 59: 649.
11. Sun J, Sheil AGR, Wang C, et al. Tolerance to rat liver allografts IV. Tolerance depends on the quantity of donor tissue and on donor leucocytes. Transplantation 1996; 62: 1725.
12. Murase N, Starzl T, Tanabe M, et al. Variable chimerism, graft versus host disease, and tolerance induction after different kinds of cell and solid organ transplantation from Lewis to Brown-Norway rats. Transplantation 1995; 60: 158.
13. Sun J, McCaughan G, Gallagher N, Sheil A, Bishop G. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995; 60: 233.
14. Shimizu Y, Goto S, Lord R, et al. Restoration of tolerance to rat hepatic allografts by spleen-derived passenger leucocytes. Transplant Int 1996; 9: 593.
15. Bishop GA, Sun J, DeCruz DJ, et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol 1996; 156; 4925.
16. Qian S, Demetris A, Murase N, Rao A, Fung J, Starzl T. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
17. Thomson A, Lu L, Wan Y, Qian S, Larsen C, Starzl T. Identification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients. Transplantation 1995; 60: 1555.
18. Murase N, Starzl T, Ye Q, et al. Multilineage haematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With particular reference to the liver. Transplantation 1996; 61: 1.
19. Tu Y, Arima T, Flye M. Rejection of spontaneously accepted rat liver allografts with recipient interleukin-2 treatment or donor irradiation. Transplantation 1997; 63: 177.
20. Sriwatanawongsa V, Davies H, Calne R. The essential roles of parenchymal tissues and passenger leucocytes in the tolerance induced by liver grafting in rats. Nature Med 1995; 1: 428.
21. Kamada N, Teramoto K. Cellular basis of transplantation tolerance induced by liver grafting in the rat. Transplantation 1988; 46: 165.
22. Kobayashi E, Kamada N, Delriviere L, et al. Migration of donor cells into the thymus is not essential for induction and maintenance of systemic tolerance after liver transplantation in the rat. Immunology 1995; 84: 333.
23. Rokahr K, Sharland A, Sun J, et al. Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation. Immunology 1998; 95: 257.
24. Kelso A, Munck A. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones. J Immunol 1984; 133: 784.
25. Arya S, Wong-Staal F, Gallo R. Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J Immunol 1984; 133: 273.
26. Konieczny B, Dai Z, Elwood E, et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell co-stimulation pathways. J Immunol 1998; 160: 2059.
27. Dai Z, Konieczny B, Baddoura F, Lakkis F. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2 deficient mice. J Immunol 1998; 161: 1659.
28. Li XC, Zheng XX, Strom TB. T cell growth factors in allograft rejection and tolerance. Transplant Proc 1999 (in press).
29. Kamada N, Calne R. A surgical experience with 530 liver transplants in the rat. Surgery 1983; 93: 64.
30. Fabre J, Lim SH, Morris PJ. Renal transplantation in the rat: details of a technique. Aust NZ J Surg 1971; 41: 69.
31. Kline R, Churchill M, Churchill P, Bidani A, Schwartz M. High osmolality-low pH flush solutions improve renal transplant function in rats. Urol Res 1991; 19: 81.
32. Torras J, Bordalba J, Seron D, et al. An experimental comparison between isotonic saline solution, Euro-Collins and a flush solution with mannitol in the prevention of damage due to warm ischaemia. Transplant Proc 1992; 24(1): 45.
33. Tilney NL. Patterns of lymphatic drainage in the adult laboratory rat. J Anat 1971; 109: 369.
34. Bishop GA, Hall BM, Duggin GG, Horvath JS, Sheil AGR, Tiller DJ. Immunopathology of renal allograft rejection analysed with monoclonal antibodies to mononuclear cell markers. Kidney Int. 1986; 29: 708.
35. Sun J, McCaughan GW, Matsumoto Y, Sheil AG, Gallagher ND, Bishop GA. Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 1994; 57: 1349.
36. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
37. Bishop G, Rokahr K, Lowes M, et al. Quantitative reverse transcriptase-PCR amplification of cytokine mRNA in liver biopsy specimens using a non-competitive method. Immunol Cell Biol 1997; 75: 142.
38. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
39. + T cells. Eur J Immunol 1991; 21: 1187.
40. Lowes M, Bishop G, Crotty K, Barnetson R, Halliday G. T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas. J Invest Dermatol 1997; 108: 914.
41. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493.
42. Van Engeland M, Ramaekers F, Schutte B, Reutlingsperger C. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 1996; 24: 131.
43. Bergese S, Klenotic S, Wakely M, Sedmak D, Orosz C. Apoptosis in murine cardiac grafts. Transplantation 1997; 63: 320.
44. Critchfield J, Zuniga-Pflucker J, Lenardo M. Parameters controlling the programmed death of mature mouse T lymphocytes in high-dose suppression. Cell Immunol 1995; 160: 71.
45. Kabelitz D, Pohl T, Pechold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 1993; 14: 338.
46. Lynch D, Ramsdell F, Alderson M. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995; 16: 569.
47. Lu L, Qian S, Hershberger P, Rudert W, Lynch D, Thomson A. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 1997; 158: 5676.
48. Bishop G, Sun J, Sheil A, McCaughan G. High dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation 1997; 64: 1377.
49. b in the liver. Eur J Immunol 1995; 25: 1932.
50. + T lymphocytes but fail to promote survival. Eur J Immunol 1998; 28: 221.
51. O'Brien I, Reutlingsperger C, Holdaway K. Annexin-V and TUNEL use in monitoring the progression of apoptosis in plants. Cytometry 1997; 29: 28.
52. Critchfield J, Racke M, Zuniga-Pflucker J, et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994; 263: 1139.
53. Moskophidis D, Lechner F, Pircher H, Zinkernagel R. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector cells. Nature 1993; 362: 758.
54. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990; 63: 1249.
55. Smith K. Interleukin-2: inception, impact and implications. Science 1988; 240: 1169.
56. + T cells. Annu Rev Immunol 1994; 12: 635.
57. Lenardo MJ. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 1991; 353: 858.
58. Kneitz B, Herrmann T, Yonehara S, Schimpl A. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur J Immunol 1995; 25: 2572.
59. + T cells. Eur J Immunol 1996; 26: 2263.
60. Van Parijs L, Biuckians A, Ibragimov A, Alt F, Willerford D, Abbas A. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J Immunol 1997; 158: 3738.
61. Sadlack B, Merz H, Schorle H, Schimpl A, Feller A, Horak I. Ulcerative colitis-like disease in mice with disrupted interleukin-2 gene. Cell 1993; 75: 253.
62. Willerford D, Chen J, Ferry J, Davidson L, Ma A, Alt F. Interleukin-2 receptor a-chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3: 521.
63. Suzuki H, Kundig T, Furlonger C, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 1995; 268: 1472.
64. Bishop G, Sharland A, McCaughan G. High-dose/activation-associated tolerance model for allografts: Lessons from spontaneous tolerance of transplanted livers. Curr Opin Organ Transplant 1999; 4: 58-64.
65. Kroemer G, Martinez-AC. Pharmacological inhibition of programmed cell death. Immunol Today 1994; 15: 235.
66. Sackstein R, Borenstein M. The effects of corticosteroids on lymphocyte recirculation in humans: analysis of the mechanism of impaired lymphocyte migration to lymph node following methyulprednisolone administration. J Invest Med 1995; 43: 68.
67. Wang C, Sheil A, McCaughan G, Bishop G, Sun J. Effect of methylprednisolone on rat liver transplant tolerance and rejection. Immunol Cell Biol 1997; 75: A150.
68. D'Adamio F, Zollo O, Moraca R, et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 1997; 7: 803.
69. Staruch M, Sigal N, Dumont F. Differential effects of the immunosuppressive macrolides FK506 and rapamycin on activation-induced T-cell apoptosis. Int J Immunopharm 1991; 13: 677
70. Anel A, Buferne M, Boyer C, Schmitt-Verhulst A-M, Golstein P. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 1994; 24: 2469.
71. Brunner T, Yoo N, LaFace D, Ware C, Green D. Activationinduced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int Immunol 1996; 8: 1017.
72. Yazdanbaksh K, Choi J, Li Y, Lau L, Choi Y. Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77. Proc Natl Acad Sci USA 1995; 92: 437.
73. Walter D, Haendeler J, Galle J, Zeiher A, Dimmeler S. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation 1998; 98: 1153.
74. Chatenoud L. Biological immunosuppressants: the way to clinical transplantation tolerance. Transplant Proc 1997; 29: 51.
75. Larsen C, Elwood E, Alexander D, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
76. Opelz G and the Collaborative Transplant Study Group. Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Transplantation 1995; 60: 1220.